Beam Therapeutics Inc. SEC filings BEAM
Beam Therapeutics Inc. has 514 filings in SEC EDGAR's recent list, going back to Aug 9, 2018. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| 4 | Insider transaction | Oct 16, 2026 | Oct 15, 2026 |
| 144 | Notice of proposed sale | Oct 16, 2026 | — |
| 144 | Notice of proposed sale | Oct 15, 2026 | — |
| 4 | Insider transaction | Oct 2, 2026 | Oct 1, 2026 |
| 4 | Insider transaction | Sep 25, 2026 | Sep 24, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 4 | Insider transaction | Jul 29, 2026 | Jul 27, 2026 |
| 144 | Notice of proposed sale | Jul 27, 2026 | — |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 29, 2026 |
| 144 | Notice of proposed sale | Jun 30, 2026 | — |
| 144 | Notice of proposed sale | Jun 29, 2026 | — |
| 4 | Insider transaction | Jun 29, 2026 | Jun 25, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 29, 2026 | — |
| ARS | Annual report to shareholders | Apr 17, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 17, 2026 | — |
| DEF 14A | Proxy statement | Apr 17, 2026 | Jun 3, 2026 |
| 144 | Notice of proposed sale | Apr 14, 2026 | — |
| 4 | Insider transaction | Apr 6, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 6, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 6, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 6, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 6, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 144 | Notice of proposed sale | Mar 31, 2026 | — |
| 144 | Notice of proposed sale | Mar 31, 2026 | — |
| 144 | Notice of proposed sale | Mar 31, 2026 | — |
| 144 | Notice of proposed sale | Mar 31, 2026 | — |
| 144 | Notice of proposed sale | Mar 31, 2026 | — |
| 144 | Notice of proposed sale | Mar 30, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| 8-K |
Current report
Agreement ended
|
Mar 5, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Feb 26, 2026 | Feb 24, 2026 |
| 144 | Notice of proposed sale | Feb 24, 2026 | — |
| S-8 | Employee stock plan registration | Feb 24, 2026 | — |
| 10-K | Annual report | Feb 24, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Results of operations, New debt
|
Feb 24, 2026 | Feb 24, 2026 |
| 8-K |
Current report
Material agreement
|
Feb 12, 2026 | Feb 9, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 9, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Feb 5, 2026 | Jan 31, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 3, 2026 | — |
| 4 | Insider transaction | Feb 2, 2026 | Jan 31, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 31, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 31, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 31, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 29, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 31, 2026 |
| 144 | Notice of proposed sale | Jan 30, 2026 | — |
| 144 | Notice of proposed sale | Jan 29, 2026 | — |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 144 | Notice of proposed sale | Jan 22, 2026 | — |
| 4 | Insider transaction | Jan 21, 2026 | Jan 20, 2026 |
| 4 | Insider transaction | Jan 20, 2026 | Jan 15, 2026 |
| 144 | Notice of proposed sale | Jan 15, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 11, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Acquisition or sale of assets
|
Dec 11, 2025 | Dec 8, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 5, 2025 | — |
| 10-Q | Quarterly report | Nov 4, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2025 | Nov 4, 2025 |
| 4 | Insider transaction | Oct 29, 2025 | Oct 27, 2025 |
| 4 | Insider transaction | Oct 8, 2025 | Oct 6, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Oct 1, 2025 |
| 144 | Notice of proposed sale | Oct 2, 2025 | — |
| 144 | Notice of proposed sale | Oct 1, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 7, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 6, 2025 | — |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2025 | Aug 5, 2025 |
| 4 | Insider transaction | Aug 1, 2025 | Jul 30, 2025 |
| 4 | Insider transaction | Jul 3, 2025 | Jul 1, 2025 |
| 8-K |
Current report
Unregistered share sale
|
Jul 3, 2025 | Jul 1, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2025 | Jun 4, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 13, 2025 | — |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| ARS | Annual report to shareholders | Apr 18, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 18, 2025 | — |
| DEF 14A | Proxy statement | Apr 18, 2025 | Jun 4, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 17, 2025 | — |
| 3 | Initial insider ownership | Apr 10, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 3, 2025 | Apr 1, 2025 |
| 4 | Insider transaction | Apr 3, 2025 | Apr 1, 2025 |
| 4 | Insider transaction | Apr 3, 2025 | Apr 1, 2025 |
| 4 | Insider transaction | Apr 3, 2025 | Apr 1, 2025 |
| 4 | Insider transaction | Apr 3, 2025 | Apr 1, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 144 | Notice of proposed sale | Apr 2, 2025 | — |
| 4/A | Filing | Apr 2, 2025 | Jan 30, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 2, 2025 | — |
| 144 | Notice of proposed sale | Mar 31, 2025 | — |
| 144 | Notice of proposed sale | Mar 31, 2025 | — |
| 144 | Notice of proposed sale | Mar 31, 2025 | — |
| 144 | Notice of proposed sale | Mar 31, 2025 | — |
| 424B5 | Prospectus supplement | Mar 10, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Mar 10, 2025 | Mar 10, 2025 |
| FWP | Free writing prospectus | Mar 10, 2025 | — |
| 424B5 | Prospectus supplement | Mar 10, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 10, 2025 | Mar 10, 2025 |
| S-8 | Employee stock plan registration | Feb 25, 2025 | — |
| 10-K | Annual report | Feb 25, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2025 | Feb 25, 2025 |
| 4 | Insider transaction | Feb 20, 2025 | Feb 18, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 144 | Notice of proposed sale | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2025 | — |
| 4 | Insider transaction | Feb 3, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Feb 3, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Feb 3, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Feb 3, 2025 | Jan 30, 2025 |
| 4 | Insider transaction | Feb 3, 2025 | Jan 31, 2025 |
| 144 | Notice of proposed sale | Jan 30, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 13, 2025 | Jan 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 10, 2025 | — |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 2, 2025 | Dec 31, 2024 |
| 144 | Notice of proposed sale | Dec 30, 2024 | — |
| 144 | Notice of proposed sale | Dec 30, 2024 | — |
| 4 | Insider transaction | Dec 19, 2024 | Dec 17, 2024 |
| 3 | Initial insider ownership | Dec 19, 2024 | Dec 19, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 9, 2024 | Dec 7, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 6, 2024 | Dec 5, 2024 |
| 4 | Insider transaction | Dec 4, 2024 | Dec 2, 2024 |
| 3 | Initial insider ownership | Dec 4, 2024 | Dec 2, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 4, 2024 | Dec 2, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| 4 | Insider transaction | Nov 8, 2024 | Nov 6, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 8, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 7, 2024 | — |
| 10-Q | Quarterly report | Nov 5, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Other events
|
Nov 5, 2024 | Nov 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 5, 2024 | Nov 5, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2024 | Nov 5, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 21, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 17, 2024 | — |
| 4 | Insider transaction | Oct 16, 2024 | Oct 14, 2024 |
| 144 | Notice of proposed sale | Oct 15, 2024 | — |
| 144 | Notice of proposed sale | Oct 7, 2024 | — |
| 4 | Insider transaction | Oct 2, 2024 | Oct 1, 2024 |
| 4 | Insider transaction | Oct 2, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Oct 2, 2024 | Sep 30, 2024 |
| 144 | Notice of proposed sale | Sep 30, 2024 | — |
| 4 | Insider transaction | Sep 3, 2024 | Aug 31, 2024 |
| 3 | Initial insider ownership | Aug 19, 2024 | Aug 9, 2024 |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 15, 2024 | Jul 11, 2024 |
| 4 | Insider transaction | Jul 3, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Jun 28, 2024 | Jun 27, 2024 |
| 144 | Notice of proposed sale | Jun 27, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- BEAM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1745999
- Former names
- Beam Therapeutics Inc. (until Nov 3, 2026)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.